mug135 Antibody

What is mug135 Antibody and what organism does it target?

mug135 Antibody (Product Code: CSB-PA524902XA01SXV) is a polyclonal antibody raised in rabbits against recombinant Schizosaccharomyces pombe (strain 972 / ATCC 24843), commonly known as fission yeast. The antibody specifically targets the mug135 protein, which is identified by Uniprot number O74876. This antibody has been developed specifically for research applications involving S. pombe and has been affinity-purified to ensure specificity to the target protein . The development approach aligns with standard immunization protocols used in generating research-grade antibodies for model organism studies, similar to approaches used for other specialized monoclonal and polyclonal antibodies in research settings .

What are the validated experimental applications for mug135 Antibody?

The mug135 Antibody has been specifically validated for enzyme-linked immunosorbent assay (ELISA) and Western blot (WB) applications. These validation processes ensure reliable identification of the antigen in experimental conditions . When designing experiments, researchers should consider that this antibody has not been validated for other common applications such as immunohistochemistry (IHC), immunoprecipitation (IP), or flow cytometry. This contrasts with more broadly validated antibodies like CU-P2-20 and CU-28-24, which have demonstrated efficacy across multiple applications including ELISA, immunoblotting, and in some cases IHC . For research requiring alternative detection methods, additional validation would be necessary.

How should mug135 Antibody be stored to maintain optimal activity?

The manufacturer recommends storing mug135 Antibody at either -20°C or -80°C upon receipt. It is critical to avoid repeated freeze-thaw cycles as these can significantly degrade antibody activity over time . The antibody is supplied in a storage buffer containing 0.03% Proclin 300 as a preservative and 50% glycerol in 0.01M PBS at pH 7.4, which helps maintain stability during storage . For working solutions, aliquoting the antibody into single-use volumes before freezing is recommended to prevent protein degradation from multiple freeze-thaw cycles. This approach to antibody storage aligns with standard practices for preserving antibody functionality, similar to protocols used for other research antibodies described in immunological research .

What is the expected lead time for obtaining mug135 Antibody?

The mug135 Antibody is typically made-to-order with an expected lead time of 14-16 weeks . This extended production timeline reflects the specialized nature of this research reagent and the quality control processes involved in its production. Researchers should incorporate this significant lead time into their experimental planning to avoid delays in research progress. Compared to commercially available antibodies against more common targets, this represents a substantially longer production timeline, highlighting the specialized nature of this reagent.

What are the optimal dilution ratios for mug135 Antibody in ELISA and Western blot applications?

For ELISA applications, the recommended starting dilution for mug135 Antibody is typically 1:1000, though this should be optimized based on the specific experimental conditions and signal requirements. For Western blot applications, starting dilutions of 1:500 to 1:1000 are generally appropriate, with optimization recommended for each specific experimental setup . Establishing a dilution curve during initial experiments is advisable to determine the optimal antibody concentration that provides maximum specific signal with minimal background. This methodological approach parallels standard antibody titration protocols used with other research antibodies, where systematic optimization enhances experimental reproducibility and data quality .

How can researchers validate the specificity of mug135 Antibody in their experimental systems?

To validate mug135 Antibody specificity, researchers should implement multiple control experiments:

• Positive control: Use purified recombinant mug135 protein or cell lysates from wild-type S. pombe (strain 972) known to express the target protein.

• Negative control: Include samples from knockout or knockdown S. pombe strains lacking mug135 expression.

• Peptide competition assay: Pre-incubate the antibody with excess purified mug135 protein before application to verify that binding is blocked, confirming specificity.

• Cross-reactivity testing: Test against related species or proteins to confirm selective binding.

These validation approaches align with standard methodologies used in antibody characterization studies and are similar to validation protocols implemented for other research antibodies . Proper validation ensures experimental results accurately reflect true biological phenomena rather than non-specific interactions.

What modifications to standard protocols might be necessary when using mug135 Antibody with difficult samples?

When working with challenging samples, several protocol modifications may improve results:

• For limited protein samples: Increase antibody incubation time to 12-16 hours at 4°C rather than standard 1-2 hour incubations at room temperature.

• For high background issues: Implement more stringent blocking conditions using 5% BSA or 5% non-fat milk in TBS-T for 2 hours at room temperature.

• For weak signals: Consider signal amplification methods such as biotin-streptavidin systems or enhanced chemiluminescence substrates.

• For membrane proteins: Optimize lysis buffers to include appropriate detergents (e.g., 1% Triton X-100) to efficiently solubilize membrane-associated proteins.

These methodological adaptations follow similar principles to those used with other antibodies in challenging research contexts, where systematic optimization of experimental conditions improves detection sensitivity and specificity .

How does mug135 Antibody perform in detecting post-translational modifications of the target protein?

The capability of mug135 Antibody to detect post-translational modifications (PTMs) of the target protein has not been specifically validated. Researchers investigating PTMs should first confirm whether the antibody's epitope overlaps with potential modification sites. For comprehensive PTM analysis, complementary approaches such as mass spectrometry, phospho-specific antibodies, or mobility shift assays should be considered alongside mug135 Antibody detection . This multi-method approach parallels advanced protein characterization strategies used in studies of other proteins where post-translational regulation is significant, such as those observed in studies examining glycosylation patterns of cancer-associated proteins .

What strategies can be employed to improve detection sensitivity when working with low abundance mug135 protein?

For detecting low abundance mug135 protein, researchers can implement several sensitivity-enhancing strategies:

• Sample enrichment: Use immunoprecipitation or affinity purification to concentrate the target protein before analysis.

• Signal amplification: Employ tyramide signal amplification (TSA) or polymer-based detection systems to enhance signal intensity.

• Extended exposure times: For Western blots, use longer exposure times with high-sensitivity chemiluminescent substrates.

• Reduced antibody dilution: Use higher concentrations of primary antibody, though this requires careful balance to avoid increased background.

• Sample loading optimization: Maximize protein loading while maintaining gel resolution.

These approaches align with sensitivity enhancement methods used in advanced antibody-based detection systems described in immunological research literature , where detection limits are systematically improved through methodological refinements.

Can computational approaches enhance experimental design when working with mug135 Antibody?

Computational approaches can significantly enhance experimental design and interpretation when working with mug135 Antibody:

• Epitope prediction: Use bioinformatics tools to predict the likely epitope regions on mug135 protein, informing sample preparation methods.

• Cross-reactivity analysis: Employ sequence alignment tools to identify potential cross-reactive proteins that share sequence homology with mug135.

• Structure prediction: Use protein structure prediction tools to understand the accessibility of antibody binding sites in native versus denatured conditions.

• Experimental condition modeling: Utilize statistical design of experiments (DoE) to systematically optimize multiple parameters simultaneously.

This integration of computational and experimental approaches reflects modern research methodologies used in antibody-based studies, where in silico analysis guides wet-lab experimental design to improve efficiency and reproducibility .

What sample preparation techniques are optimal for detecting mug135 in S. pombe cell lysates?

Optimal sample preparation for detecting mug135 in S. pombe lysates involves several critical steps:

• Cell wall disruption: Use glass bead lysis in a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 10% glycerol, and 1% Triton X-100.

• Protease inhibition: Include a complete protease inhibitor cocktail to prevent protein degradation during lysis.

• Phosphatase inhibitors: Add 1 mM sodium orthovanadate, 10 mM sodium fluoride, and 1 mM PMSF if analyzing phosphorylated forms.

• Centrifugation: Clear lysates by centrifugation at 14,000 × g for 15 minutes at 4°C.

• Protein quantification: Use BCA or Bradford assay to standardize loading amounts.

This methodological approach mirrors established protocols for protein extraction from yeast cells while incorporating specific considerations for preserving the target protein's integrity and native state . The method draws from standard practice in protein biochemistry while addressing the specific challenges of working with yeast cell walls.

How can researchers optimize blocking conditions to reduce non-specific binding when using mug135 Antibody?

To optimize blocking conditions and minimize non-specific binding:

• Blocking agent comparison: Systematically test 5% BSA, 5% non-fat milk, and commercial blocking buffers to identify optimal performance.

• Blocking duration: Extend blocking time to 2 hours at room temperature or overnight at 4°C for challenging samples.

• Detergent optimization: Adjust Tween-20 concentration in wash buffers (0.05-0.1%) to reduce hydrophobic non-specific interactions.

• Pre-adsorption: For samples with known cross-reactivity, pre-adsorb the antibody with the cross-reactive protein or with lysates from negative control samples.

• Sequential blocking: Implement a two-step blocking process using different blocking agents for particularly challenging samples.

This systematic approach to optimization reflects best practices in immunodetection methodology and parallels optimization strategies used with other research-grade antibodies in complex experimental systems .

What is the recommended approach for troubleshooting weak or absent signals when using mug135 Antibody?

When encountering weak or absent signals with mug135 Antibody, implement this systematic troubleshooting approach:

• Antibody validation: Confirm antibody activity using a positive control sample containing known levels of target protein.

• Sample integrity: Verify protein integrity by visualizing total protein using a reversible stain or examining housekeeping proteins.

• Protocol optimization sequence:

  • Reduce antibody dilution (use higher concentration)

  • Extend primary antibody incubation (overnight at 4°C)

  • Increase sample loading

  • Enhance detection sensitivity using high-sensitivity substrates

  • Modify lysis conditions to improve target protein extraction

• Alternative detection methods: If Western blot fails consistently, attempt ELISA as an alternative detection method .

• Epitope accessibility: Consider native versus denaturing conditions if the epitope might be masked in certain conformations.

This methodical troubleshooting approach follows established practices in antibody-based detection optimization and incorporates principles used in addressing detection challenges with various research antibodies .

What potential cross-reactivity might be expected with mug135 Antibody across different yeast species?

The mug135 Antibody has been specifically validated for reactivity with Schizosaccharomyces pombe (strain 972 / ATCC 24843) . Cross-reactivity with other yeast species is possible and depends on sequence homology with the mug135 protein. Researchers working with other yeast species should:

• Perform sequence alignment analysis comparing mug135 from S. pombe with potential homologs in the species of interest.

• Validate cross-reactivity experimentally using positive and negative controls from each species.

• Consider epitope mapping to identify if the recognized region is conserved across species.

This analytical approach to cross-reactivity assessment parallels methods used in antibody characterization studies where species specificity is systematically evaluated to establish the range of experimental applicability .

How can researchers distinguish between specific and non-specific binding patterns in their experimental systems?

To differentiate between specific and non-specific binding:

• Implement multiple controls:

  • Primary antibody omission control

  • Isotype control (rabbit IgG at equivalent concentration)

  • Pre-immune serum control (if available)

  • Peptide competition assay

  • Knockout/knockdown controls

• Analyze binding patterns:

  • Specific binding typically produces distinct bands/signals at the expected molecular weight

  • Non-specific binding often presents as multiple bands, smears, or background

• Validate with orthogonal methods:

  • Confirm findings using alternative detection methods

  • Corroborate results with published literature on mug135 expression patterns

This systematic approach to specificity validation follows established principles in antibody characterization and mirrors methods used to establish specificity in other antibody-based research applications .

What emerging research applications might benefit from mug135 Antibody detection systems?

Emerging research applications that could benefit from mug135 Antibody detection include:

• Cell cycle regulation studies in S. pombe, as many mug (meiotically upregulated gene) family proteins are involved in cell cycle control.

• Comparative studies of stress response mechanisms across yeast species, particularly those involving cellular adaptation to environmental changes.

• Investigation of protein-protein interaction networks in fission yeast, using mug135 Antibody in co-immunoprecipitation experiments followed by mass spectrometry analysis.

• Development of biosensor applications for detecting specific yeast strains in environmental or industrial samples.

These prospective applications reflect emerging trends in yeast biology research while building upon established methodologies in antibody-based detection systems .

How does the development of mug135 Antibody compare with other antibodies targeting yeast proteins in terms of research applications?

The development of mug135 Antibody represents a specialized addition to the toolkit for S. pombe research. Compared to antibodies targeting more conserved yeast proteins (like tubulin or actin), mug135 Antibody offers highly specific detection of a protein with more specialized functions. This specificity comes with both advantages (reduced cross-reactivity with conserved proteins) and limitations (narrower range of applicable species).

Unlike some commercially available antibodies against major yeast proteins that offer validation across multiple applications (immunofluorescence, flow cytometry, etc.), mug135 Antibody has been specifically validated for ELISA and Western blot applications . This reflects a common pattern in specialized research antibodies, where validation is often initially limited to the most common applications, with broader application potential requiring further validation by end-users .